Founded in 2015 and headquartered in London, Isomer Capital focuses on backing early-stage European tech startups by investing in venture capital funds and directly in companies. The firm has made 30 investments and raised five funds, including the €250 million Isomer Capital III and the Isomer Capital Secondaries I fund. Notable investments include Latent Labs, a biotech company leveraging AI for drug discovery, and Knowunity, an AI companion for students. Isomer Capital has also invested in prominent companies such as UiPath, Revolut, and Darktrace.
Is Isomer Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Isomer Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Seed, Series A
First ticket size
€1,500,000 - €10,000,000
When approaching Isomer Capital, founders should highlight how their startup fits into the broader European tech ecosystem and demonstrate strong traction or validation from other top-tier investors. Emphasize your company’s potential for outsized growth and scalability, as Isomer often co-invests alongside leading funds and values clear signals of market fit. Articulate how your technology or business model stands out in a competitive landscape, and be prepared to discuss your long-term vision and ability to attract follow-on capital.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.